Wednesday, 17th April 2012 - Analytical Services International (ASI) at St George’s, University of London, UK, has been evaluating LoGiCal certified reference materials – a new product range from LGC Standards – for its therapeutic drug monitoring (TDM) services, where high quality reference standards are an essential requirement. The use of high quality reference materials is equally important for the Company’s international proficiency testing scheme for immunosuppressive drugs, co-ordinated by Professor David Holt. ASI recently validated the use of LoGiCal solutions of the immunosuppressant mycophenolic acid (MPA) and antiarrhythmic amiodarone metabolite desethylamiodarone (DEA) in its assays.
Michelle Moreton-Clack, TDM Service Manager, explained: “As part of our therapeutic drug monitoring service, we run assays for the measurement of MPA and DEA. We usually buy the drugs in powder form and weigh them out to prepare stock solutions for our assays. The LoGiCal range includes ISO Guide 34 certified solutions of MPA and DEA, which are really easy to use and save a lot of time by eliminating weighing stages. We validated both compounds against our existing stock solutions, and they showed good correlation; I am very pleased with the results.”
About LGC Standards
LGC Standards (www.lgcstandards.com) provides products and services to improve measurement and quality control within the laboratory, and is part of LGC, whose LGC Science & Technology Division acts as the UK National Measurement Institute for chemical and bioanalytical measurements. LGC Standards supplies over 100,000 products, including reference materials, pharmaceutical impurity reference standards (produced under ISO Guide 34 accreditation), biological standards and reagents, and proficiency testing. LGC Standards is headquartered in Teddington, Middlesex, UK. Its global centre for excellence in proficiency testing is located in Bury (Greater Manchester). LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, Russia, United Arab Emirates and the UK, a joint venture presence in India, and representatives in Brazil, Bulgaria, Czech Republic, Finland, Hungary, Ireland, the Netherlands, Romania, Turkey and the US.
About LGC
LGC (www.lgcgroup.com) is the international science-based company and market leader in analytical, forensic, biotechnology and diagnostic services, as well as diagnostic products, proficiency testing and reference standards. LGC operates in a variety of international markets which underpin the safety, health and security of the public and the regulation of industry, for both public and private sector clients. LGC has five divisions - LGC Forensics, LGC Genomics, LGC Health Sciences, LGC Standards and LGC Science & Technology. The latter includes specialist laboratories delivering contracts for the Department for Business, Innovation and Skills (BIS) and supports LGC's designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement. Our operations are extensively accredited to international quality standards such as ISO/IEC 17025. With headquarters in Teddington, South West London, the LGC Group employs over 1,600 staff in 36 laboratories and centres globally. Privatised in 1996 and now majority-owned by funds managed by Bridgepoint, LGC was founded 170 years ago as the Laboratory of the Government Chemist - a statutory function maintained by LGC today.
For further information contact:
Deborah Gaskell
Group Communications Manager
LGC
Queens Road, Teddington
Middlesex
TW11 0LY
UK
Tel: +44 (0)20 8943 7563
Fax: +44 (0)20 8943 2767
Email: [email protected]
Web: www.lgcgroup.com
Follow LGC Standards on twitter: http://twitter.com/LGCStds_For
Follow LGC's Science blog: www.blog.lgcgroup.com